Brief: Regeneus Agrees To Merge With Cambium Medical Technologies
April 28 (Reuters) - Regeneus Ltd RGS.AX :
* AGREES TO MERGE WITH CAMBIUM MEDICAL TECHNOLOGIES
* SIGNED A NON-BINDING INDICATIVE OFFER LETTER TO MERGE WITH
CAMBIUM MEDICAL TECHNOLOGIES, LLC
* CONSIDERATION FOR ACQUISITION OF SHARES WILL BE ISSUE OF
NEW
ORDINARY SHARES IN REGENEUS
* NEWLY ISSUED SHARES TO CMT SHAREHOLDERS WILL REPRESENT 50%
OF
REGENEUS POST-TRANSACTION ISSUED SHARE CAPITAL
Source text for Eikon: ID:nASXD1GZJ
Further company coverage: RGS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cambium Bio
See all newsAustralia's Cambium Bio hits near three-month high on share placement at premium
Brief: Cambium Bio Appoints Olga Smejkalova As Company Secretary
Australia's Cambium Bio gains after premium share placement
Brief: Cambium Bio Raises A$1 MLN At A$0.48 Per Share
Brief: Cambium Bio Receives A$2.4 Million Investment From Zheng Yang Biomedical Technology